Azam U, Humayun W, Avathan Veettil A, Liu Y, Hasturk O, Jiang M
RSC Med Chem. 2025; .
PMID: 39990167
PMC: 11841741.
DOI: 10.1039/d4md00770k.
Aloui M, El Fadili M, Mujwar S, Er-Rahmani S, Abuelizz H, Er-Rajy M
Heliyon. 2024; 10(19):e38383.
PMID: 39397921
PMC: 11467593.
DOI: 10.1016/j.heliyon.2024.e38383.
Aloui M, Er-Rajy M, Imtara H, Goudzal A, Zarougui S, El Fadili M
Saudi Pharm J. 2024; 32(1):101911.
PMID: 38226346
PMC: 10788635.
DOI: 10.1016/j.jsps.2023.101911.
Jablonska-Trypuc A, Wydro U, Wolejko E, Makula M, Kretowski R, Naumowicz M
Molecules. 2023; 28(21).
PMID: 37959855
PMC: 10648374.
DOI: 10.3390/molecules28217437.
Bujor A, Hanganu A, Tecuceanu V, Madalan A, Tudose M, Marutescu L
Antioxidants (Basel). 2023; 12(3).
PMID: 36978960
PMC: 10045258.
DOI: 10.3390/antiox12030713.
Molecular Physicochemical Properties of Selected Pesticides as Predictive Factors for Oxidative Stress and Apoptosis-Dependent Cell Death in Caco-2 and HepG2 Cells.
Silva A, Martins-Gomes C, Ferreira S, Souto E, Andreani T
Int J Mol Sci. 2022; 23(15).
PMID: 35897683
PMC: 9331544.
DOI: 10.3390/ijms23158107.
In Vitro Assessment of Pesticides Toxicity and Data Correlation with Pesticides Physicochemical Properties for Prediction of Toxicity in Gastrointestinal and Skin Contact Exposure.
Silva A, Martins-Gomes C, Silva T, Coutinho T, Souto E, Andreani T
Toxics. 2022; 10(7).
PMID: 35878283
PMC: 9317861.
DOI: 10.3390/toxics10070378.
Design, synthesis, and biological evaluation of C-difluoromethylenated epoxymorphinan Mu opioid receptor antagonists.
Kassick A, Treat A, Tomycz N, Feasel M, Kolber B, Averick S
RSC Med Chem. 2022; 13(2):175-182.
PMID: 35308026
PMC: 8864491.
DOI: 10.1039/d1md00285f.
Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.
Tan Y, Barton H, Boobis A, Brunner R, Clewell H, Cope R
Regul Toxicol Pharmacol. 2021; 127:105070.
PMID: 34718074
PMC: 9229944.
DOI: 10.1016/j.yrtph.2021.105070.
Isavuconazole: Thermodynamic Evaluation of Processes Sublimation, Dissolution and Partition in Pharmaceutically Relevant Media.
Olkhovich M, Sharapova A, Blokhina S, Perlovich G
Molecules. 2021; 26(16).
PMID: 34443346
PMC: 8398847.
DOI: 10.3390/molecules26164759.
QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase.
Daoui O, Elkhattabi S, Chtita S, Elkhalabi R, Zgou H, Benjelloun A
Heliyon. 2021; 7(7):e07463.
PMID: 34296007
PMC: 8282965.
DOI: 10.1016/j.heliyon.2021.e07463.
Synthesis, Crystallography, and Anti-Leukemic Activity of the Amino Adducts of Dehydroleucodine.
Ordonez P, Mery D, Sharma K, Nemu S, Reynolds W, Enriquez R
Molecules. 2020; 25(20).
PMID: 33092263
PMC: 7588005.
DOI: 10.3390/molecules25204825.
QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2.
Umar A, Uzairu A, Shallangwa G, Uba S
Heliyon. 2020; 6(3):e03640.
PMID: 32258485
PMC: 7110328.
DOI: 10.1016/j.heliyon.2020.e03640.
Optimization and Evaluation of Site-Identification by Ligand Competitive Saturation (SILCS) as a Tool for Target-Based Ligand Optimization.
Ustach V, Lakkaraju S, Jo S, Yu W, Jiang W, MacKerell Jr A
J Chem Inf Model. 2019; 59(6):3018-3035.
PMID: 31034213
PMC: 6597307.
DOI: 10.1021/acs.jcim.9b00210.
Prediction of partition and distribution coefficients in various solvent pairs with COSMO-RS.
Tshepelevitsh S, Hernits K, Leito I
J Comput Aided Mol Des. 2018; 32(6):711-722.
PMID: 29846868
DOI: 10.1007/s10822-018-0125-y.
Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
Li H, Wang X, Yu H, Zhu J, Jin H, Wang A
Curr Neuropharmacol. 2017; 16(6):758-768.
PMID: 29086699
PMC: 6080099.
DOI: 10.2174/1570159X15666171030142108.
Aromatase inhibitory activity of 1,4-naphthoquinone derivatives and QSAR study.
Prachayasittikul V, Pingaew R, Worachartcheewan A, Sitthimonchai S, Nantasenamat C, Prachayasittikul S
EXCLI J. 2017; 16:714-726.
PMID: 28827987
PMC: 5547393.
DOI: 10.17179/excli2017-309.
Shallow Representation Learning via Kernel PCA Improves QSAR Modelability.
Rensi S, Altman R
J Chem Inf Model. 2017; 57(8):1859-1867.
PMID: 28727421
PMC: 5942586.
DOI: 10.1021/acs.jcim.6b00694.
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies.
Andrade E, Bento A, Cavalli J, Oliveira S, Freitas C, Marcon R
Braz J Med Biol Res. 2016; 49(11):e5644.
PMID: 27783811
PMC: 5089235.
DOI: 10.1590/1414-431X20165644.
Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification.
Prachayasittikul V, Pingaew R, Anuwongcharoen N, Worachartcheewan A, Nantasenamat C, Prachayasittikul S
Springerplus. 2015; 4:571.
PMID: 26543706
PMC: 4628044.
DOI: 10.1186/s40064-015-1352-5.